Why the study?
Does complement depletion prevent fatal systemic shock following intestinal ischaemia in rats?
Does complement depletion prevent fatal systemic shock following intestinal ischaemia in rats?
Complement activation and subsequent anaphylatoxin generation play a crucial role in inducing fatal systemic shock following intestinal ischaemia in rats.
Complement depletion may attenuate fatal shock in rat intestinal ischaemia; leaves open translation to human therapy.
Intestinal ischaemia lasting more than 30 min in rats causes fatal systemic shock. Systemic shock was suppressed by preadministration of cobra venom factor (CVF), which reduced the serum complement to less than 5% of the normal level, indicating that complement is involved in the syndrome. After complement activation, anaphylatoxins such as C3a and C5a are generated, and their activity is restricted by carboxypeptidases which remove C-terminal arginine from such bioactive peptides. As expected, preadministration of a carboxypeptidase inhibitor enhanced the systemic shock induced by the intestinal ischaemia. However, when the complement level was suppressed by CVF treatment, no fatal systemic shock was induced by the intestinal ischaemia even with preadministration of the carboxypeptidase inhibitor. These results indicate that complement plays a crucial role in systemic shock induced by intestinal ischaemia, and that anaphylatoxins generated by the complement activation should be involved in induction of the shock syndrome.
No takes yet. Share an insight, caveat, or question.
Ikai et al. (1996) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: